Home > Pressrelease > Vascular Graft Market worth over $3.3bn by 2027

Vascular Graft Market worth over $3.3bn by 2027

  • Published Date: July 12, 2021

Vascular Graft Market size is set to surpass USD 3.3 billion by 2027, according to a new research report by Global Market Insights Inc.

The rising prevalence of diabetes as well as cardiac arrests are some of the primary concerns propelling the market growth in developing economies. For instance, it is estimated that nearly 60% of global diabetes population resides in countries of APAC and around 50% reside in China and India combined. Hence, the increased burden of diabetes in the region is expected to optimistically impact the market expansion. Further, the occurrence of kidney failures also requires kidney transplant, a process that largely employs vascular grafts. The reconstruction of renal vessel in a kidney transplant employs vascular grafts and a rising incidence of end-stage kidney failure is poised to drive the demand for vascular grafts products.


Rising incidences of cardiovascular diseases & growing adoption of unhealthy diet will foster the vascular graft market progression

Growing acceptance of unhealthy diet along with interrelated habits such as alcohol consumption and tobacco smoking has augmented number of people suffering from chronic conditions. Increasing incidences of cardiovascular diseases will stimulate the demand for vascular grafts. Treatment for cardiovascular diseases include angioplasty, stent insertion, atherectomy, and vascular bypass grafting of which, vascular bypass grafting is the most common procedure. Further, high prevalence of hypertension is due to behavioral-risk factors such as physical inactivity, obesity, high salt intake and alcohol abuse. These factors will largely contribute to increasing incidence of cardiovascular diseases.

Infection associated with vascular graft may slow down the market demand

Vascular graft infections are one of the serious barriers in revenue growth of the market. For instance, according to a study published in Cardiovascular Pathology, the infection rate of implanted vascular prosthesis is 6% globally. The standard technique to treat vascular graft infections involves complete graft removal followed by extra bypass procedure. This involves complicated procedures and reduces the success rate of grafting. Moreover, vascular graft infections treatment increases hospital stay, thereby escalating hospital expenditure.

Higher adoption of peripheral vascular repair procedures will spur the segment growth

The peripheral vascular repair segment accounted for 21.4% of the vascular graft market share in 2020 led by the high prevalence rate of peripheral arterial disease. Peripheral artery disease can also lead to critical limb ischemia if blood flow to the limbs is blocked by or severely restricted. Therefore, development of critical limb ischemia is associated with serious complications.

Browse key industry insights spread across 150 pages with 205 market data tables & 14 figures & charts from the report, “Vascular Graft Market Size By Raw Material (Polyester Grafts, EPTFE Grafts, Polyurethane Grafts, Biosynthetic Grafts), By Application (Endovascular Aneurysm Repair {Abdominal Aortic Aneurysm Repair, Thoracic Aortic Aneurysm Repair}, Peripheral Vascular Repair, Hemodialysis Access), By End-use (Hospitals, Ambulatory Surgical Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:

Technological advancements in the conventional EPTFE graft will lead to its increased demand in the future

The EPTFE segment in the vascular graft market will showcase 6% growth rate through 2027. EPTFE graft is broadly used in hemodialysis access, peripheral vascular surgery and extra-anatomical procedures. Technological advancements in the conventional EPTFE graft will lead to its higher demand in the future.

Ability of ambulatory surgical centers to offer single day cardiovascular surgery and lower healthcare costs will further favor the segment expansion

Ambulatory surgical centers segment exceeded USD 559.3 million in 2020 impelled by the rising demand for short hospital stays and cost-effective treatments for various cardiovascular disorders. Furthermore, ability of ambulatory surgical centres to offer single day cardiovascular surgery and lower healthcare-associated costs will further favour the ambulatory surgical centre segment value during the forecast period.

Development and biomaterial based vascular grafts have overcome complications associated with conventional grafts that has enhanced the market revenue

Europe vascular graft market is predicted to reach USD 947.7 million by 2027. Frequent upgradation of technology allows introduction of innovative and advanced vascular grafts. Also, development of minimally invasive and biomaterial based vascular grafts have overcome complications associated with conventional grafts that has accelerated the industry growth. Additionally, increasing prevalence of chronic disease such as diabetes and atherosclerosis among other disease will further fuel the industry expansion.

Industry players are focusing on launching various vascular graft product to boost the market value

Prominent companies operating in the global market are Becton Dickinson (C.R. Bard), B. Braun Melsungen, Cryolife (Jotec), Cook Medical, Endologix, and LeMaitre Vascular among others. The market leaders undertake various strategic initiatives to gain a competitive edge in the industry.

Authors: Sumant Ugalmugle, Rupali Swain

Explore More on Related Topics: